After Thursday’s meeting … Japan is moving towards adopting remdisevir for treatment

0
49


Minister of Health: We would like it to be used by those suffering from serious conditions as soon as possible

Japanese Health Minister Katsunobu Kato said that the Geladis Sciences anti-retroviral drug Remediver may be approved by Tokyo to treat Covid-19 patients when the review panel meets on Thursday.

Last week, the US Food and Drug Administration approved the emergency use of this drug to treat Covid-19, a highly contagious lung disease caused by the emerging corona virus.

And the company, “Gilead Sciences” applied for speedy approval of its use in Japan on Monday.

According to Russia today, Kato said on a TV news program today, that if the review panel approves this drug, he intends to approve it immediately.

“Once it is imported, we would like it to be used by those suffering from serious conditions as soon as possible.”

On Monday, Prime Minister Shinzo Abe extended the state of emergency across the country until May 31, saying the incidence of the new Coronavirus has not decreased enough to justify ending measures to slow the outbreak.
Although Japan has not experienced a major outbreak, compared to some hotspots around the world, there are over 16,000 recorded infections and 579 deaths, according to the Japan Radio and Television Corporation.

Japanese Health Minister
Katsunobu Kato
New Corona Virus

After Thursday’s meeting … Japan is moving towards adopting the remediffer drug to treat corona

Already

Japanese Health Minister Katsunobu Kato said that the Geladis Sciences anti-retroviral drug Remediver may be approved by Tokyo to treat Covid-19 patients when the review panel meets on Thursday.

Last week, the US Food and Drug Administration approved the emergency use of this drug to treat Covid-19, a highly contagious lung disease caused by the emerging corona virus.

And the company, “Gilead Sciences” applied for speedy approval of its use in Japan on Monday.

According to Russia today, Kato said on a TV news program today, that if the review panel approves this drug, he intends to approve it immediately.

“Once it is imported, we would like it to be used by those suffering from serious conditions as soon as possible.”

On Monday, Prime Minister Shinzo Abe extended the state of emergency across the country until May 31, saying the incidence of the new Coronavirus has not decreased enough to justify ending measures to slow the outbreak.
Although Japan has not experienced a major outbreak, compared to some hotspots around the world, there are over 16,000 recorded infections and 579 deaths, according to the Japan Radio and Television Corporation.

May 05, 2020 – Ramadan 12, 1441

09:12 PM


Minister of Health: We would like it to be used by those suffering from serious conditions as soon as possible

Japanese Health Minister Katsunobu Kato said that the Geladis Sciences anti-retroviral drug Remediver may be approved by Tokyo to treat Covid-19 patients when the review panel meets on Thursday.

Last week, the US Food and Drug Administration approved the emergency use of this drug to treat Covid-19, a highly contagious lung disease caused by the emerging corona virus.

And the company, “Gilead Sciences” applied for speedy approval of its use in Japan on Monday.

According to Russia today, Kato said on a TV news program today, that if the review panel approves this drug, he intends to approve it immediately.

“Once it is imported, we would like it to be used by those suffering from serious conditions as soon as possible.”

On Monday, Prime Minister Shinzo Abe extended the state of emergency across the country until May 31, saying the incidence of the new Coronavirus has not decreased enough to justify ending measures to slow the outbreak.
Although Japan has not experienced a major outbreak, compared to some hotspots around the world, there are over 16,000 recorded infections and 579 deaths, according to the Japan Radio and Television Corporation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here